Radiopharmaceutical Supply – Therapeutic Isotopes (I-131)

The contract entails the supply of Iodine-131 in both capsule and liquid formulations for the treatment of thyroid cancer and hyperthyroidism, with strict requirements for proper packaging and labeling to ensure safety and regulatory compliance. Delivery must be executed on a time-sensitive schedule due to the radioactive decay properties of Iodine-131, necessitating precise logistics and coordination to maintain therapeutic efficacy. The product must meet all applicable standards for radiopharmaceuticals and be ready for immediate clinical use upon arrival. This subcontract is issued under the Department of Veterans Affairs through Network Contract Office 19, with performance required at a location in Muskogee, Oklahoma, with a zip code of 74401. The opportunity was posted on May 11, 2026, and responses are due by May 18, 2026, at 3:00 PM. The NAICS code 325412 identifies the industry as pharmaceutical preparation manufacturing, indicating the supplier must have the technical capability and regulatory certifications to handle radioactive isotopes. The solicitation does not specify any set-aside provisions and does not list a point of contact, suggesting vendors should rely on official SAM.gov resources for further details.